Because this payment demonstration operates outside coverage under a Part D plan, the $50 copayment toward these medications will not count toward a participating beneficiarys Part D deductible or the $2,100 out-of-pocket maximum in 2026 (increasing to $2,400 in 2027), and copayments will stay consistent at $50 per month, regardless of the Part D benefit phase a beneficiary is in when they fill the prescription
Thats why all the experts interviewed for this story said its imperative that you talk to your doctor for specific dosing advice, rather than following tips from TikTok influencers
Tirzepatide is technically a dual GIP and GLP-1 receptor agonist, but many patients group it with GLP-1 weight-loss injections because it affects the GLP-1 pathway
Heres the reality check: Drinking oats this way may raise GLP-1 in the body slightly, but its not anything like these injections, Rao says
Our healthcare providers engage in comprehensive discussions with each candidate, taking into account their medical history, current health conditions, and weight loss goals
Remove the patch from its liner
